MX2009009133A - Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona. - Google Patents

Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona.

Info

Publication number
MX2009009133A
MX2009009133A MX2009009133A MX2009009133A MX2009009133A MX 2009009133 A MX2009009133 A MX 2009009133A MX 2009009133 A MX2009009133 A MX 2009009133A MX 2009009133 A MX2009009133 A MX 2009009133A MX 2009009133 A MX2009009133 A MX 2009009133A
Authority
MX
Mexico
Prior art keywords
naloxone
buprenorphine
medicinal compositions
improved medicinal
composition
Prior art date
Application number
MX2009009133A
Other languages
English (en)
Inventor
Christopher Bourne Chapleo
Neil Hyde
Original Assignee
Reckitt Benckiser Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare filed Critical Reckitt Benckiser Healthcare
Publication of MX2009009133A publication Critical patent/MX2009009133A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Se proporciona una composición para el tratamiento de dolor en pacientes humanos en donde dicha composición comprende buprenorfina a naloxona en una relación en peso de 2.1:1 a 8:1, la cantidad de buprenorfina y naloxona es adecuada para proporcionar analgesia, la composición está en una forma de dosificación transdérmica o transmucósica. También se proporciona un método y uso relacionado.
MX2009009133A 2007-03-01 2008-02-15 Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona. MX2009009133A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0703967A GB2447015A (en) 2007-03-01 2007-03-01 Analgesic composition comprising a specific ratio of buprenorphine and naltrexone
PCT/GB2008/000523 WO2008104737A1 (en) 2007-03-01 2008-02-15 Improved medicinal compositions comprising buprenorphine and naloxone

Publications (1)

Publication Number Publication Date
MX2009009133A true MX2009009133A (es) 2009-09-03

Family

ID=37965734

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009009133A MX2009009133A (es) 2007-03-01 2008-02-15 Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona.

Country Status (16)

Country Link
US (1) US20100168147A1 (es)
EP (1) EP2114453A1 (es)
JP (1) JP2010520185A (es)
KR (1) KR20090115863A (es)
CN (2) CN101622013A (es)
AR (1) AR065581A1 (es)
AU (1) AU2008220573A1 (es)
BR (1) BRPI0807905A2 (es)
CA (1) CA2678675A1 (es)
CL (1) CL2008000610A1 (es)
GB (1) GB2447015A (es)
MX (1) MX2009009133A (es)
PE (1) PE20081874A1 (es)
TW (1) TW200836738A (es)
WO (1) WO2008104737A1 (es)
ZA (1) ZA200905691B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101230804B1 (ko) 2006-07-21 2013-02-08 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 향상된 흡수를 갖는 경점막 전달 장치
ES2663777T3 (es) * 2008-06-23 2018-04-17 Biodelivery Sciences International, Inc. Dispositivos de administración mucosa multidireccionales y métodos de uso
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
CA3119258A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US20130071477A1 (en) 2011-09-19 2013-03-21 Orexo Ab New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US20140275148A1 (en) * 2013-03-15 2014-09-18 Novus Pharma LLC Orally administrable, self-supporting dissolving film dosage forms
CA2875384A1 (en) 2013-12-20 2015-06-20 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
CN106163499A (zh) 2014-03-14 2016-11-23 欧皮安特制药有限公司 鼻用药物产品及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
UA53774C2 (uk) * 1997-12-22 2003-02-17 Еро-Селтік, С.А. Спосіб запобігання зловживанню лікарськими формами, що містять опіоїди
AR031682A1 (es) * 1999-11-19 2003-10-01 Reckitt Benckiser Helthcare Uk Composiciones farmaceuticas
PT1526848E (pt) * 2002-08-09 2007-08-08 Gruenenthal Gmbh Antagonistas dos receptores de opióides em sistemas transdérmicos contendo buprenorfina
US20050191340A1 (en) * 2002-08-09 2005-09-01 Gruenenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
US8236751B2 (en) * 2007-03-07 2012-08-07 The Johns Hopkins University Methods of increasing muscle mass using follistatin-like related gene (FLRG)

Also Published As

Publication number Publication date
WO2008104737A1 (en) 2008-09-04
CN101622013A (zh) 2010-01-06
TW200836738A (en) 2008-09-16
AR065581A1 (es) 2009-06-17
GB0703967D0 (en) 2007-04-11
CN102670610A (zh) 2012-09-19
AU2008220573A1 (en) 2008-09-04
CA2678675A1 (en) 2008-09-04
US20100168147A1 (en) 2010-07-01
CL2008000610A1 (es) 2008-09-05
PE20081874A1 (es) 2009-01-26
JP2010520185A (ja) 2010-06-10
ZA200905691B (en) 2010-10-27
BRPI0807905A2 (pt) 2014-06-17
EP2114453A1 (en) 2009-11-11
GB2447015A (en) 2008-09-03
KR20090115863A (ko) 2009-11-09

Similar Documents

Publication Publication Date Title
MX2009009133A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y naloxona.
MX2009009132A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y naltrexona.
HK1139871A1 (en) Improvements in and relating to medicinal compositions
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
IL244974B (en) Preparations in flat form containing buprenorphine and naloxone, formulations in flat form containing them, and their use in the preparation of drugs for the treatment of narcotic dependence
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
MX2010002392A (es) Composiciones de brimonidina mejoradas para tratar eritema.
HUP0203588A2 (hu) Fájdalomcsillapító hatású gyógyszerkészítmények és alkalmazásuk
PT1730147E (pt) Compostos de 1,4,8-triazaspiro[4.5]decan-2-ona substituídos para utilização no tratamento da obesidade
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
JP2010520186A5 (es)
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
TW200806318A (en) Uses of anti-insulin-like growth factor I receptor antibodies
CL2011002248A1 (es) Composicion farmaceutica oral de liberacion inmediata que comprende oxicodona y naloxona en una proporcion 2:1 en peso; uso de la composicion farmaceutica para tratar dolor intercurrente en paciente que sufren de dolor.
NZ589733A (en) Oral administration of peripherally-acting opioid antagonists
JP2010520183A5 (es)
MXPA06013133A (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
JP2010520185A5 (es)
MX2009009134A (es) Composiciones medicinales mejoradas que comprenden buprenorfina y nalmefeno.
TNSN08506A1 (en) Substituted carboxamides
NZ719087A (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
MX2009013197A (es) Derivados terapeuticos de pirazolonaftiridina.
MX367580B (es) El uso de lapatinib o una sal o composición farmacéuticamente aceptable del mismo para el tratamiento del cáncer.
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.

Legal Events

Date Code Title Description
GB Transfer or rights